1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Florida >
  6. DifGen Acquires Aveva

M&A Deal Summary

DifGen Acquires Aveva

On April 24, 2023, DifGen acquired life science company Aveva from Apotex

Acquisition Highlights
  • This is DifGen’s 1st transaction in the Life Science sector.
  • This is DifGen’s 1st transaction in the United States.
  • This is DifGen’s 1st transaction in Florida.

M&A Deal Summary
Date 2023-04-24
Target Aveva
Sector Life Science
Buyer(s) DifGen
Sellers(s) Apotex
Deal Type Divestiture

Target

Aveva

Miramar, Florida, United States
AVEVA is a transdermal drug delivery provider. The company provides pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. Aveva was founded in 1991 and is based in Miramar, Florida.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DifGen

Princeton, New Jersey, United States
Category Company
Sector Life Science
DESCRIPTION

DifGen is a pharmaceutical company with a primary focus on developing complex high barrier to entry Generics and Specialty Pharmaceutical products that would help increase accessibility to high-quality medication thereby leading to the creation of next-generation healthy communities. DifGen is based in Princeton, New Jersey.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Divestiture M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 2
Year: 2023 M&A 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-11 KriGen

Lillington, North Carolina, United States

KriGen is a fully integrated sterile drug product manufacturer with the capability to manufacture a wide range of parenteral products including LVP bags (both Aseptic & Terminally Sterilized), PFS, Microspheres& complex Long Acting Injectables. KriGen is based in Lillington, North Carolina.

Buy -

Seller(S) 1

SELLER

Apotex

Toronto, Ontario, Canada
Category Company
Founded 1974
Sector Life Science
DESCRIPTION

Apotex is an independent pharmaceutical company committed to R&D, manufacturing, and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers, and governments worldwide. Apotex was founded in 1974 and is based in Toronto, Ontario.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-19 Starplex Scientific

Etobicoke, Ontario, Canada

Starplex Scientific, Inc. manufacturers leak-resistant sample collectors and pharmaceutical/ nutraceutical bottles. Starplex Scientific, Inc. products include specimen containers, transport vials, collectors, swab tips and shafts, O-ring containers, buckets, and tissue cassettes. Starplex Scientific, Inc. serves the healthcare, environmental/industrial, veterinary and pharmaceutical/ nutraceutical sectors in North America.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-02 Searchlight Pharma

Montreal, Quebec, Canada

Searchlight Pharma is a specialty healthcare company that offers acquisition, commercialization, and focused development of innovative and unique specialty healthcare products. Searchlight Pharma was founded in 2015 and is based in Montreal, Quebec.

Buy -
Mergr

Solution for

Product

Company

Legal